Research Articles

The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children.

Graham SM, Grzemska M, Gie RP

Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia.

Rodrigo C, Eltahla AA, Bull RA, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Estes C, Razavi H, Lloyd AR, Luciani F, International Collaborative of Incident HIV and Hepatitis C in Injecting Cohorts (InC3) Study Group

High mobility, low access thwarts interventions among seasonal workers in the Greater Mekong Sub-region: lessons from the malaria containment project.

Canavati SE, Quintero CE, Lawford HL, Yok S, Lek D, Richards JS, Whittaker MA

Perspectives on the methods of a large systematic mapping of maternal health interventions.

Chersich M, Becerril-Montekio V, Becerra-Posada F, Dumbaugh M, Kavanagh J, Blaauw D, Thwala S, Kern E, Penn-Kekana L, Vargas E, Mlotshwa L, Dhana A, Mannava P, Portela A, Tristan M, Rees H, Bijlmakers L

Antibody responses to Plasmodium falciparum and Plasmodium vivax blood-stage and sporozoite antigens in the postpartum period.

McLean AR, Boel ME, McGready R, Ataide R, Drew D, Tsuboi T, Beeson JG, Nosten F, Simpson JA, Fowkes FJ

The changing landscape of hepatitis C treatment-not 'can we cure?' but 'who should we cure first?' Is this an ethical approach?

Hellard M, Scott N